Avoid common mistakes on your manuscript.
Dear Reader,
Welcome to the final issue of Drugs—Real World Outcomes for 2023.
We would like to reflect on this year’s achievements and to thank all those who have contributed their valuable time and effort to the journal over the past 12 months.
We would like to start by thanking the authors of the articles published in Drugs—Real World Outcomes over the course of 2023. The skill and dedication of these experts is critical to the continued success of the journal.
We are excited to share the news that Drugs—Real World Outcomes received its first Impact Factor of 2.0 in the Journal Citation Reports™ (Clarivate) in June 2023. The high quality of articles published in Drugs—Real World Outcomes has also been reflected in the most recent CiteScore of 2.9.
The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would therefore like to thank the following individuals who acted as reviewers for Drugs—Real World Outcomes in the last 12 months:
Emma Aarnio, Finland
Nafees Ahmad, Pakistan
Eman A. Alghamdi, Saudi Arabia
Nebyu D. Amaha, Ethiopia
Mary S. Anthony, USA
Michael Auer, Austria
Nobutaka Ayani, Japan
Maria Antonietta Barbieri, Italy
Jeffrey Berinstein, USA
Cesare Berra, Italy
Achenef M. Beyene, Ethiopia
Kim Blond, Denmark
Richard Bockman, USA
Ivana Bojanić, Norway
Vittorio Bolcato, Italy
Sander Borgsteede, the Netherlands
Stefan Braune, Germany
Rachel Britt, USA
Marta J. Brooks, USA
Shawn Bugden, Canada
Anthony Buisson, France
Héctor Cabello-Rangel, Mexico
Andrea Camerini, Italy
Sankha S. Chakrabarti, India
Javier Cid Ruzafa, Spain
Antonio Clavenna, Italy
Ineke Crijns, the Netherlands
Heather Danysh, USA
Catherine G. Derington, USA
Christopher J. Destache, USA
Mark A. Dusheiko, Switzerland
Trevor Ellison, USA
Kenneth Ernest-Suarez, Canada
Tesfahun Eshetie, Australia
Augusto Ferraris, Argentina
Francesca Fiorentino, Italy
Leorah Freeman, USA
Jun Fujinaga, Japan
Masaki Fujita, Japan
Vittorio Gebbia, Italy
Evangelos Giamarellos-Bourboulis, Greece
Sergey Golubev, Belarus
Gisela Gonzalez, Argentina
Swarnali Goswami, USA
Verena Gotta, Switzerland
Jing Gu, USA
Deniz Can Guven, Turkey
Mario Habek, Croatia
Mohammad H. Hashempur, Islamic Republic of Iran
Delfina F. Hlashwayo, Mozambique
Kazuya Hosokawa, Japan
John E. Hughes, Ireland
Kenya Ie, Japan
Ryo Iketani, Japan
Sushmitha Inguva, USA
Dolores Isla, Spain
Tianze Jiao, USA
Ted Johnson, USA
Michalis Katsoulis, UK
Hideki Katsura, Japan
Karel Kostev, Germany
Ashwath Kumar, USA
Katrin Kurvits, Estonia
Joëlle Lanser, the Netherlands
Leire Leache, Spain
Willem Lems, the Netherlands
Anne-Marie Leroi, France
Tingting Li, USA
Weijia Li, USA
Xiaotong Li, USA
David Liew, Australia
Junjing Lin, USA
Andrea Lindsey, USA
Hideki Maeda, Japan
Dederieke Maes-Festen, the Netherlands
Seyed H. Mahmoudpour, Germany
Mortimier M. Mamelak, Canada
Andrea Margulis, Spain
Clara Marquina, Australia
Lubov Matchekhina, The Russian Federation
Rano Matta, Canada
Geert Mayer, Germany
Nobuaki Michihata, Japan
Motoyasu Miyazaki, Japan
Marcello Moccia, Italy
Cliff Molife, USA
Yola Moride, USA
Robert P. Morris, USA
Tinashe Mudzviti, Zimbabwe
Milena Murray, USA
Junko Nagai, Japan
Sujita Narayan, Australia
Mamoru Narukawa, Japan
Takatoshi Nawa, Japan
Ole Haagen Nielsen, Denmark
Rajeshwar Nitiyanandan, USA
Jenny M. Norlin, Sweden
Tetsuya Okano, Japan
Shunsuke Ono, Japan
Khalid Orayj, Saudi Arabia
Kampadilemba Ouoba, Burkina Faso
Thanh Phuong Pham Nguyen, USA
Sherman Picardo, Canada
Maurizio Pompili, Italy
Sergio I. Prada, Colombia
Mahbubur Rashid, Australia
Nazia Rashid, USA
Jayachandran Ravichandran, USA
Itamar Raz, Israel
Anthony T. Reder, USA
Sanika Rege, USA
Joseph Reilly, USA
Jose Rocha, Portugal
Albert Roger, Spain
Yossi Rosman, Israel
Barbara Ruaro, Italy
Cristina Ruas, Brazil
Masataka Sawaki, Japan
Rajani Sharma, India
Lunda Shen, USA
Tadashi Shimizu, Japan
Tahreem G. Siddiqui, Norway
Eva Sönnerstam, Sweden
Ross A. Soo, Singapore
Patrick Souverein, the Netherlands
Marios Spanakis, Greece
Dorothea Strobach, Germany
Matej Stuhec, Slovenia
Thanarat Suansanae, Thailand
Vinita Subramanya, USA
Yasuaki Tagashira, Japan
Masahiro Takeshima, Japan
Masato Takeuchi, Japan
Sandra Thiel, Germany
Glenn S. Tillotson, USA
Kanae Togo, Japan
Francesco Tovoli, Italy
Dat T. Tran, Canada
Masami Tsuchiya, Japan
Kiyotaka Uchiyama, Japan
Maria Valdovinos, USA
Wout van den Broek, the Netherlands
Daisy Volmer, Estonia
Jingjun Wang, USA
Tzu-Chueh Wang, Taiwan, Republic of China
Sawaeng Watcharathanakij, Thailand
Maureen B. G. Wissing, the Netherlands
Saranrat Wittayanukorn, USA
Zongqi Xia, USA
Chen Yang, China
Yizhou Ye, USA
Changhoon Yoo, Republic of Korea
Pedro Zapater, Spain
Dongmu Zhang, USA
Huanxue Zhou, USA
We gratefully acknowledge all the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:
Dr G. Caleb Alexander, MD. Johns Hopkins University, Baltimore, MD, USA.
Associate Professor W. Alsabbagh, PhD. University of Waterloo, Kitchener, ON, Canada
Dr Ariel Beresniak, MD MPH PhD. Data Mining International, Geneva, Switzerland.
Dr Juliana M. Bottomley, PhD. Amygdala Ltd, Letchworth Garden City, England.
Dr Juanita Breen, PhD, MSc, BPharm. University of Tasmania, Hobart, TAS, Australia.
Dr Maria Stella T. Giron, MD, PhD. University of the Philippines Manila, Manila, Philippines.
Dr Brian Godman, PhD. Karolinska Institutet, Stockholm, Sweden.
Dr David Goldsmith, MD. Goldsmith Pharmacovigilance and Systems, New York, NY, USA.
Professor Maria Gustafsson, PhD. University of Umea, Umea, Sweden.
Dr Klejda Harasani, PhD. University of Medicine, Tirana, Albania.
Dr Emily Karanges, PhD. University of Melbourne and Orygen, Parkville, VIC, Australia.
Dr Sudeep Karve, PhD. AbbVie, Chicago, IL, USA.
Dr Ronald Kiguba, PhD. Makerere University, Kampala, Uganda.
Dr Shunsuke Kiuchi, MD, PhD. Toho University Graduate School of Medicine, Tokyo, Japan.
Dr Chris M. Kozma, PhD. CK Consulting Associates, St. Helena Island, SC, USA.
Dr Tamar Lasky, PhD. U.S. Food and Drug Administration, Silver Spring, MD, USA.
Dr Giancarlo Lucchetti, MD, PhD. Federal University of Juiz de Fora, Juiz de Fora, Brazil.
Professor Jorge E. Machado-Alba, MD, PhD. Universidad Tecnologica de Pereira, Pereira, Colombia.
Adjunct Professor Diego Macías Saint-Gerons, PhD. University of Valencia/INCLIVA Health Research Institute and CIBERSAM, Valencia, Spain.
Professor Arduino A.Mangoni, MD, PhD, FRCP, FRACP. Flinders University, Adelaide, SA, Australia.
Dr Suzana Mimica-Matanovic, MD, PhD. University Hospital Osijek, Osijek, Croatia.
Professor Mihoko Okada, PhD. Institute of Health Data Infrastructure for All, Tokyo, Japan.
Dr Tasuku Okui, PhD. Kyushu University Hospital, Fukuoka, Japan.
Dr Alexandra C. Pacurariu, PhD. IQVIA, London, United Kingdom.
Dr Vidhya Parameswaran, MPH. AstraZeneca, Cambridge, MA, USA
Dr Priyakumari Ganesh Parmar, PhD. Auckland University of Technology, Auckland, New Zealand.
Dr Ana V. Pejčić, PhD, MPharm. University of Kragujevac, Kragujevac, Serbia.
Professor Barbara Rinaldi, PhD. University of Capania Luigi Vanvitelli, Naples, Italy.
Dr Melissa H. Roberts, PhD. University of New Mexico, Albuquerque, NM, USA.
Dr Mulugeta Russom, MSc. Eritrea National Medicines and Food Administration, Asmara, Eritrea.
Professor Tsuyoshi Shiga, MD. The Jikei University School of Medicine, Tokyo, Japan.
Dr Janet K. Sluggett, BPharm(Hons), PhD. Monash University, Parkville, VIC, Australia.
Dr Keith A. Swanson, PharmD. University of Oklahoma, Oklahoma City, OK, USA.
Dr Balamurugan Tangiisuran, PhD, MPharm, BPharm. Universiti Sains Malaysia, Penang, Malaysia.
Dr Florence van Hunsel, PharmD. The Netherlands PharmacovigilanceCentre Lareb, Brabant, The Netherlands.
Dr John E. Ware Jr., PhD. John Ware Research Group Incorporated,Watertown, MA, USA.
Dr Quan Zou, PhD. Medstar Health Research Institute, Washington, DC, USA.
Through the hard work of our authors and reviewers, we continue to see great gains in article usage. The most popular recent articles to date, in terms of downloads from SpringerLink, were:
Wakabayashi R, Hirano T, Laurent T, et al. Impact of “time zero” of Follow-Up Settings in a Comparative Effectiveness Study Using Real-World Data with a Non-user Comparator: Comparison of Six Different Settings. Drugs—Real World Outcomes 2022; 10: 107–117. https://link.springer.com/article/10.1007/s40801-022-00343-1.
Macías Saint-Gerons D, Ibarz MT, Castro JL, et al. Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase. Drugs—Real World Outcomes 2023; 10: 263–270. https://link.springer.com/article/10.1007/s40801-023-00355-5.
Furuse J, Izumi N, Motomura K, et al. Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan. Drugs—Real World Outcomes 2023; 10: 195–205. https://link.springer.com/article/10.1007/s40801-022-00348-w.
Gudeman J and Burroughs D. Evidence of Accidental Dosing Errors with Immediate-Release Sodium Oxybate: Data from the US Food and Drug Administration Adverse Event Reporting System. Drugs—Real World Outcomes 2023; 10: 225–234. https://link.springer.com/article/10.1007/s40801-023-00351-9.
Lee P, Kistler KD, Douyon L, et al. Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma. Drugs—Real World Outcomes 2023; 10: 11–22. https://link.springer.com/article/10.1007/s40801-022-00332-4
We hope that you have found the articles published throughout 2023 to be both interesting and informative. We have appreciated the high quality of content contributed to the journal and we look forward to keeping you up to date with topical issues in in 2024.
With best wishes,
Dene Peters
Editor-in-Chief, Drugs—Real World Outcomes
Sophie Stevenson
Associate Editor, Drugs—Real World Outcomes
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Acknowledgement to Referees. Drugs - Real World Outcomes 10, 499–502 (2023). https://doi.org/10.1007/s40801-023-00404-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40801-023-00404-z